View in Other Languages

MMJ Group Holdings Ltd

ASX:MMJ ISIN:AU000000MMJ4

Phytotech Medical ASX:PYL

MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: http://www.mmjphytotech.com.au/investors/

    

News

MMJ Group Holdings Ltd (ASX:MMJ) Commonly asked questions

🕔12/10/2018 10:05:35 AM 864

MMJ Group Holdings Limited (ASX:MMJ) (ETR:2P9) (OTCMKTS:MMJJF) ("MMJ") is pleased to provide answers to commonly asked questions on the structure, strategy, performance and outlook for MMJ.

Read Full Article

MMJ Group Holdings Ltd (ASX:MMJ) Additional information regarding shareholding in Harvest One

🕔12/5/2018 9:50:35 AM 1200

Further to the announcement made by MMJ Group Holdings Limited (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) on 3 December 2018 regarding its shareholding in Harvest One Cannabis Inc. (CVE:HVT), the board of directors of MMJ wishes to advise that its current strategy is to remain a major shareholder of Harvest One

Read Full Article

MMJ Group Holdings Ltd (ASX:MMJ) Shareholding in Harvest One

🕔12/3/2018 10:07:17 AM 1453

MMJ Group Holdings Limited (ASX:MMJ) confirms the expiry of its notice of intention to sell up to 5 million shares held in Harvest One Cannabis Inc. (TSX-V:HVT) that was filed in the Form 45-102F1 under Harvest One's SEDAR profile on 31 October 2018 and announced by MMJ on 1 November 2018.

Read Full Article

MMJ Group Holdings Ltd (ASX:MMJ) Harvest One (CVE:HVT) Q1 2019 Results

🕔11/30/2018 1:16:40 PM 1395

MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to note the attached news release by Harvest One Cannabis Inc. (CVE:HVT) announcing record revenues for the first quarter of fiscal 2019.

Read Full Article

MMJ Group Holdings Ltd (ASX:MMJ) MediPharm Labs (CVE:LABS) Enters Contract with Canopy Growth

🕔11/30/2018 12:23:45 PM 1356

MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to attach a copy of a news release announcing that MediPharm Labs Inc (CVE:LABS) has entered into an 18-month strategic supply agreement with Canopy Growth Corporation (TSE:WEED) (NYSE:CGC).

Read Full Article

MMJ Group Holdings Ltd (ASX:MMJ) Bien Develops Encapsulated Emulsions and Powders

🕔11/27/2018 9:50:13 AM 1297

MMJ Group Holdings Limited (ASX:MMJ) ("MMJ") is pleased to note the attached media release by Bien Ventures Ltd.

Read Full Article

MMJ Group Holdings Ltd (ASX:MMJ) Investor Presentation

🕔11/21/2018 9:26:54 AM 1484

MMJ Group Holdings Ltd (ASX:MMJ) (OTCMKTS:MMJJF) provides the Company's latest investor presentation.

Read Full Article

MMJ Group Holdings Ltd (ASX:MMJ) Role of CEO

🕔11/20/2018 4:52:09 PM 1647

Jason Conroy was appointed as Chief Executive Officer of MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) in February 2018.

Read Full Article

MMJ Group Holdings Ltd (ASX:MMJ) Completion of Sale of PhytoTech Therapeutics Ltd

🕔11/20/2018 4:51:24 PM 1453

As announced on 25 June 2018, MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) entered into a binding share sale agreement pursuant to which it conditionally agreed to sell its wholly-owned subsidiary PhytoTech Therapeutics Ltd to Harvest One Cannabis Inc. (CVE:HVT) for total consideration of CAD$8 million.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) MediPharm Labs (CVE:LABS) Enters Contract with Supreme Cannabis

🕔11/15/2018 10:44:42 AM 1739

MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to attach a copy of a news release by MediPharm Labs Inc (CVE:LABS) announcing that it has entered into a 3-year cannabis concentrate program agreement with Supreme Cannabis Company Inc (CVE:FIRE).

Read Full Article
###

78,805 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 780) (Last 30 Days: 3079) (Since Published: 63917) 

Markets ASX:MMJ

Company Data

    Headquarters
  • Suite 518, Level 5
    165-167 Phillip Street
    Sydney NSW 2000
    Australia
  • Telephone
  • +61-2-8098-0819 
  • Fax
  • +61-2-8080-8315 
  • Principal Sector
  • Ag Biotechnology 
  • Principal Industry
  • Healthcare 
  • Homepage
  • www.mmjgh.com.au
  • E:
  • info@mmjgh.com.au

Company Reports

Presentations

Research Report

Quarterly Report

Social Media